Linden Advisors’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-40,008
| Closed | -$404K | – | 575 |
|
|
2022
Q4 | $404K | Hold |
40,008
| – | – | ﹤0.01% | 349 |
|
|
2022
Q3 | $396K | Sell |
40,008
-638,841
| -94% | -$6.32M | ﹤0.01% | 439 |
|
|
2022
Q2 | $6.72M | Hold |
678,849
| – | – | 0.06% | 186 |
|
|
2022
Q1 | $6.69M | Hold |
678,849
| – | – | 0.04% | 275 |
|
|
2021
Q4 | $6.68M | Hold |
678,849
| – | – | 0.04% | 240 |
|
|
2021
Q3 | $6.61M | Hold |
678,849
| – | – | 0.04% | 259 |
|
|
2021
Q2 | $6.57M | Buy |
+678,849
| New | +$6.57M | 0.03% | 276 |
|